Skip to main content
Article thumbnail
Location of Repository

Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy

By Susan Rehm, Marilyn Campion, David E. Katz, Rene Russo and Helen W. Boucher
Topics: Original Research
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2008). A et al. Relationship between vancomycin MIC and failure among patients with MRSA bacteremia treated with vancomycin. Antimicrob Agents Chemother
    2. (2003). A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore)
    3. (1997). Adverse drug reactions in home care patients receiving nafcillin or oxacillin.
    4. (1999). Adverse effects of outpatient parenteral antibiotic therapy.
    5. (2004). An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects.
    6. (2006). Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients.
    7. (1982). Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med
    8. (2003). Comparison of mortality associated with methicillin-resistant and methicillinRehm et al. 1040susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis
    9. (2000). Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics
    10. (1996). Cost of medical care for postoperative spinal infections. Orthop Clin North Am
    11. (2009). Cubicin w (daptomycin for injection) current prescribing information.
    12. (2006). Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    13. (2008). Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    14. (2008). Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis
    15. (2004). Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
    16. (2005). Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.
    17. (2006). Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis
    18. (1992). Home Infusion Therapy: A Service and Demographic Profile: A Report for the National Alliance for Infusion Therapy. Washington, DC: National Alliance for Infusion Therapy,
    19. (1983). Home intravenous antibiotic therapy: a team approach. Ann Intern Med
    20. (2007). Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J
    21. (2005). Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease,
    22. (2008). Influence of vancomycin minimum inhibitory concentration on the treatment of methicillinresistant Staphylococcus aureus bacteremia. Clin Infect Dis
    23. (2007). Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA
    24. (1997). Management of serious staphylococcal infections in the outpatient setting. Drugs
    25. (2002). Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med
    26. (1998). Outpatient intravenous antibiotic therapy for endocarditis. Infect Dis Clin North Am
    27. (2001). Outpatient management of infective endocarditis. Curr Infect Dis Rep
    28. (2004). Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.
    29. (2006). Outpatient parenteral antibiotic therapy in Singapore.
    30. (2008). Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.
    31. (2007). Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
    32. (2001). Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis
    33. (2004). Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis
    34. (2007). Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg
    35. (1999). Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients.
    36. (2001). Rehospitalization after discharge on community-based parenteral anti-infective therapy (CoPAT). In:
    37. (2000). Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia.
    38. (2004). Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    39. (1988). Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med
    40. (1991). Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med
    41. (1994). Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial.
    42. (2004). Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis
    43. (1990). Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.